BSECompany Update1d ago · 14 Oct 2026, 05:11 pm
Submission of Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, for service agreement entered into with Franchise India Brands Limited.
Abate As Industries Ltd · 531658
✦ AI SummaryOrder Win
Abate As Industries Ltd has entered into a Franchise Development Program, Representation & Recruitment Services Agreement with Franchise India Brands Limited for expansion of the Company's eye hospital business under the brand name 'ABATE EYE HOSPITAL' through the franchise model across India.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Abate As Industries Ltd - 531658 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Attachments (1)
📄pdf
Download →
58c919d7-edd3-4c4f-8b0d-352f0e6045c5.pdf
View document text
CIN: L65990TZ1991PLC029162
Date: 14.10.2026
The Manager
Listing Compliance Department
BSE Limited
Scrip Code: 531658
Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, for service agreement entered with Franchise India
Brands Limited
With reference to the captioned subject and pursuant to Regulation 30 read with Schedule
III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we
wish to inform that the Company has entered into a Franchise Development Program,
Representation & Recruitment Services Agreement with Franchise India Brands Limited
effective from October 14, 2026 for expansion of the Company's eye hospital business
under the brand name "ABATE EYE HOSPITAL" through the franchise model across India.
The details in this regard, pursuant to Regulation 30 of the Listing Regulations read with
SEBI Master Circular No. SEBI/HO/CFD-PoD2/CIR/P/0155 dated November 11, 2024
updated circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30,
2026, is enclosed herewith as Annexure - A.
The disclosure is being made in the interest of good corporate governance and investor
awareness.
This is for your information and records.
For ABATE AS Industries Limited
Heena Kausar Rangari
Company Secretary & Compliance Officer
CIN: L65990TZ1991PLC029162
Annexure A
The details as required under the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing
Regulations”) read with the SEBI Master Circular No. SEBI/HO/CFD-PoD2/CIR/P/0155
dated November 11, 2024:
Sr. Particulars Details
1 Name(s) of parties with whom the agreement is Franchise India Brands Limited
entered
2 Purpose of entering into the agreement Franchise Development
Program, Representation &
Recruitment Services
Agreement for development of
franchise systems, franchise
documentation, lead
generation, representation and
recruitment of franchise
partners for expansion of
ABATE Eye Hospital across
India.
3 Size of agreement INR 30,00,000/- (Indian
Rupees Thirty Lakhs Only)
4 Shareholding, if any, in the entity with whom the NIL
agreement is executed
5 Significant terms of the agreement (in brief) Term of Agreement:
special rights like right to appoint directors, 24 months from the effective
first right to share subscription in case of issuance date.
of shares, right to restrict any change in capital As per the terms and
structure etc. conditions agreed between the
parties, including fixed
consultancy fees and success-
based fees linked to franchise
acquisitions.
6 Whether, the said parties are related to No
promoter/promoter group/ group companies in
CIN: L65990TZ1991PLC029162
any manner. If yes, nature of relationship
7 Whether the transaction would fall within related The transaction is not a related
party transactions? If yes, whether the same is party transaction
done at “arm’s length”.
8 In case of loan agreements, details of NA
lender/borrower, nature of the loan, total amount
of loan granted/taken, total amount outstanding,
date of execution of the loan agreement/sanction
letter, details of the security provided to the
lenders / by the borrowers for such loan or in case
outstanding loans lent to a party or borrowed from
a party become material on a cumulative basis
9 In case of issuance of shares to the parties, NA
details of issue price, class of shares issued
10 Any other disclosures related to such agreements, NA
viz., details of nominee on the board of directors of
the listed entity, potential conflict of interest
arising out of such agreements, etc.
11 In case of termination or amendment of agreement, NA
listed entity shall disclose additional details to the
stock exchange(s):
a) name of parties to the agreement;
b.) nature of the agreement;
c.) date of execution of the agreement;
d.) details of amendment and impact thereof or
reasons of termination and impact thereof.